T. Rowe Price Investment Management
MDT icon

T. Rowe Price Investment Management’s Medtronic MDT Stock Holding History

T. Rowe Price Investment Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Sell
24,100
-31,785
-57% -$2.56M ﹤0.01% 696
2026
Q1 		$4.84M Buy
55,885
+16,250
+41% +$1.56M ﹤0.01% 562
2025
Q4 		$3.81M Buy
39,635
+11,060
+39% +$1.07M ﹤0.01% 588
2025
Q3 		$2.72M Buy
28,575
+16,172
+130% +$1.49M ﹤0.01% 598
2025
Q2 		$1.08M Buy
12,403
+9,228
+291% +$783K ﹤0.01% 622
2025
Q1 		$286K Buy
+3,175
New +$284K ﹤0.01% 653

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

T. Rowe Price Investment Management's MDT Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its Medtronic (MDT) stake by 57% in Q2 2026, selling an estimated $2.56M and leaving 24,100 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #696.

T. Rowe Price Investment Management first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.84M in Q1 2026. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • T. Rowe Price Investment Management held 24,100 shares of Medtronic worth $1.89M as of Q2 2026.
  • T. Rowe Price Investment Management sold 31,785 Medtronic shares in Q2 2026, an estimated $2.56M.
  • Medtronic made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #696 holding.
  • T. Rowe Price Investment Management first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • T. Rowe Price Investment Management's Medtronic position peaked at $4.84M in Q1 2026.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.